As the gut lumen is a rich source of bacterial toxins, especially LPS, and these gut-derived mediators have been shown to participate in the pathogenesis of chronic liver inflammation/fibrosis 5, we hypothesized that the impaired gut barrier in IAP deficient mice may result in worsened liver fibrosis. The gene discussed is ALPI; the disease is fibrosis.